Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ubiquinone (1 trial)
Paralysis (Phase 2)
Supranuclear Palsy, Progressive (Phase 2)
Trials (1 total)
Trial APIs (1 total)